UT Health San Antonio Becomes First Civilian Center in South Texas To Launch FDA-Approved Radiotherapy Treatment for Advanced Prostate Cancer

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announced the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer.